Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland
Collins, Ian M., King, F., & O'Byrne, Kenneth J. (2012) Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland. Irish Journal of Medical Science, 181(3), pp. 451-452.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Additional Information:||Letter to the editor|
|Keywords:||antineoplastic agent, epidermal growth factor receptor 2, trastuzumab, drug cost, esophagus cancer, gene amplification, health care delivery, human, immunohistochemistry, Ireland, letter, major clinical study, overall survival, quality of life, stomach cancer, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Esophageal Neoplasms, Humans, Quality-Adjusted Life Years, Receptor, erbB-2, Stomach Neoplasms|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2012 Springer U K|
|Deposited On:||29 Nov 2013 04:43|
|Last Modified:||18 Dec 2013 04:37|
Repository Staff Only: item control page